AMGN vs. ABBV
Compare and contrast key facts about Amgen Inc. (AMGN) and AbbVie Inc. (ABBV).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: AMGN or ABBV.
Correlation
The correlation between AMGN and ABBV is 0.44, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Performance
AMGN vs. ABBV - Performance Comparison
Key characteristics
AMGN:
-0.35
ABBV:
0.73
AMGN:
-0.18
ABBV:
0.99
AMGN:
0.98
ABBV:
1.15
AMGN:
-0.28
ABBV:
0.88
AMGN:
-0.61
ABBV:
2.15
AMGN:
10.54%
ABBV:
8.44%
AMGN:
25.03%
ABBV:
27.49%
AMGN:
-78.02%
ABBV:
-45.09%
AMGN:
-18.06%
ABBV:
-13.55%
Fundamentals
AMGN:
$150.59B
ABBV:
$351.09B
AMGN:
$10.98
ABBV:
$2.34
AMGN:
25.51
ABBV:
84.82
AMGN:
0.95
ABBV:
0.42
AMGN:
4.41
ABBV:
6.05
AMGN:
24.36
ABBV:
105.59
AMGN:
$34.13B
ABBV:
$57.37B
AMGN:
$21.50B
ABBV:
$44.44B
AMGN:
$12.38B
ABBV:
$16.33B
Returns By Period
In the year-to-date period, AMGN achieves a 5.22% return, which is significantly lower than ABBV's 6.39% return. Over the past 10 years, AMGN has underperformed ABBV with an annualized return of 8.48%, while ABBV has yielded a comparatively higher 15.79% annualized return.
AMGN
5.22%
-2.93%
-14.12%
-8.78%
6.22%
8.48%
ABBV
6.39%
6.62%
-5.71%
19.87%
22.17%
15.79%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
AMGN vs. ABBV — Risk-Adjusted Performance Rank
AMGN
ABBV
AMGN vs. ABBV - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Amgen Inc. (AMGN) and AbbVie Inc. (ABBV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
AMGN vs. ABBV - Dividend Comparison
AMGN's dividend yield for the trailing twelve months is around 3.36%, less than ABBV's 3.44% yield.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
AMGN Amgen Inc. | 3.36% | 3.45% | 2.96% | 2.95% | 3.13% | 2.78% | 2.41% | 2.71% | 2.65% | 2.74% | 1.95% | 1.53% |
ABBV AbbVie Inc. | 3.44% | 3.49% | 3.82% | 3.49% | 3.84% | 4.41% | 4.83% | 3.89% | 2.65% | 3.64% | 3.41% | 2.54% |
Drawdowns
AMGN vs. ABBV - Drawdown Comparison
The maximum AMGN drawdown since its inception was -78.02%, which is greater than ABBV's maximum drawdown of -45.09%. Use the drawdown chart below to compare losses from any high point for AMGN and ABBV. For additional features, visit the drawdowns tool.
Volatility
AMGN vs. ABBV - Volatility Comparison
Amgen Inc. (AMGN) and AbbVie Inc. (ABBV) have volatilities of 9.94% and 10.10%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.
Financials
AMGN vs. ABBV - Financials Comparison
This section allows you to compare key financial metrics between Amgen Inc. and AbbVie Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
AMGN vs. ABBV - Profitability Comparison
AMGN - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Amgen Inc. reported a gross profit of 5.18B and revenue of 8.15B. Therefore, the gross margin over that period was 63.6%.
ABBV - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, AbbVie Inc. reported a gross profit of 11.20B and revenue of 13.34B. Therefore, the gross margin over that period was 83.9%.
AMGN - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Amgen Inc. reported an operating income of 1.18B and revenue of 8.15B, resulting in an operating margin of 14.5%.
ABBV - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, AbbVie Inc. reported an operating income of 3.73B and revenue of 13.34B, resulting in an operating margin of 28.0%.
AMGN - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Amgen Inc. reported a net income of 1.73B and revenue of 8.15B, resulting in a net margin of 21.2%.
ABBV - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, AbbVie Inc. reported a net income of 1.29B and revenue of 13.34B, resulting in a net margin of 9.6%.